Lupin arm recalls 5,720 skin treatment cream tubes in US

The affected lot has been manufactured at the company's Pithampur plant in Madhya Pradesh and marketed in the US market by Baltimore-based Lupin Pharmaceuticals Inc. The USFDA noted that the company is recalling the affected lot due to "Subpotent Drug: Low assay result observed during long-term stability testing". The company initiated the Class III nationwide (US) recall of the affected lot on January 23 this year.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/CBUtGy2
via IFTTT

0 comments:

Post a Comment